|
Aminophylline
|
D02.092.782.258.368.050 |
|
|
Niacinamide
|
D03.383.725.547.530 |
|
|
Endothelium, Corneal
|
A09.371.060.067.318 |
|
|
Anterior Chamber
|
A09.371.060.067 |
|
|
Punched-Card Systems
|
L01.224.085.800 |
|
|
Electronic Data Processing
|
L01.224.085 |
|
|
Sick Sinus Syndrome
|
C14.280.123.500.536 |
|
|
Psychotherapeutic Processes
|
F04.754.720 |
|
|
Peroxisomes
|
A11.284.430.214.190.875.190.190.755.600 |
|
|
Chemotaxis
|
F01.145.113.780.500 |
|
|
Paraganglioma
|
C04.557.465.625.650.700 |
|
|
Neuroendocrine Tumors
|
C04.557.465.625.650 |
|
|
Encephalomyelitis, Equine
|
C10.228.228.399.750.450 |
|
|
Protein Structural Elements
|
D000072416 |
[Distinguishing three-dimensional structures characteristically formed by homologous protein sequences.
] |
|
Sterol Esterase
|
D08.811.277.352.100.700 |
|
|
Protein Domains
|
D000072417 |
[Discrete protein structural units that may fold independently of the rest of the protein and have their own functions.
] |
|
Purinergic P1 Receptor Antagonists
|
D27.505.696.577.725.400.100 |
|
|
Purinergic Antagonists
|
D27.505.696.577.725.400 |
|
|
Cytomegalovirus Retinitis
|
C01.925.325.270 |
|
|
Eye Infections, Viral
|
C01.925.325 |
|
